CompoAtlas

Ketoblast 2.0 PRO

Food supplement declared in France, declaration No 2021-7-49

Ketoblast 2.0 PRO (Revogenix) is a food supplement declared in France. Status: retiré du marché le 3 June 2026. 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
Revogenix
Food business operator placing the product on the market
LABORATOIRE TERRAVITA
Status
Retiré du marché le 3 June 2026
Form
Gélule
Daily dose
4 gélules
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous antidépresseurs, Sous antidiabétiques
Objectives stated by the manufacturer (these are not authorised claims)
Minceur / Brûleur, Sport

Declaration 177046, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Marsdenia sylvestris (Retz.) P.I.Forst.FeuilleExtrait sec hydroalcoolique800 mg
Opuntia ficus-indica (L.) Mill.FeuillePoudre (de plantes séchées ou broyées)500 mg
Griffonia simplicifolia (DC.) Baill.GraineExtrait sec hydroalcoolique332 mg
Paullinia cupana KunthGraineExtrait sec aqueux30 mg

Other active ingredients

NamePer day
L-Carnitine L-Tartratenot declared
Taurinenot declared
Caféinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Picolinate de chromeChromepas de limite (données insuffisantes)25 µg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
L-pidolate de zincZinc25 mg15 mg

Additives

E470b

Other ingredients

Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Contient de la caféine 103,9 mg

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Revogenix

Enter to analyse, Shift+Enter for a new line